Why Is TWIST BIOSCIENCE COR (TWST) Stock Up Today?
By the Top Tier Newswire AI Desk · August 4, 2026 at 12:08 AM ET · reviewed against 11 wire stories
TWIST BIOSCIENCE COR (TWST) is up +10.39% in the latest session. Our newswire has captured 11 stories on TWST across 9 sources in the last 36 hours, with AI sentiment reading mixed (avg 52/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
Why TWST stock is up today
Twist Bioscience stock rose 10.39% to $101.06 in the current session, driven by the company's record third-quarter revenue and upward revision of its full-year fiscal 2026 revenue guidance. The company reported Q3 revenue of $118.4 million, a 23% year-over-year increase, marking its 14th consecutive quarter of growth. Twist Bioscience also raised its full-year revenue outlook to $456 million to $457 million from a previous range of $442 million to $447 million.
What Happened
The stock's sharp rise came after the company signaled $123 million to $124 million in Q4 revenue, exceeding the $117.546 million estimate. The Q3 earnings call highlighted strong performance in AI drug discovery and R&D momentum, reinforcing investor confidence in the company’s long-term growth prospects. Despite missing the Q3 earnings estimate with a loss of $0.56 per share, the revenue beat and raised guidance helped shift the tone of the market reaction. Canaccord Genuity maintained its Buy rating on the stock and raised its price target to $120.
What The Data Shows
The stock has moved -2.6% over the last eight sessions, from $94.08 to $91.59, before today's sharp reversal. Insider transactions over the last 90 days show 27 sales totaling $13.9 million, with no insider purchases. The stock currently trades within its 52-week range of $23.30 to $105.47, near the upper end. With a market cap of $5.7 billion, Twist Bioscience remains unprofitable, with a trailing twelve-month EPS of -1.34 and a net margin of -19.8%.
What To Watch
The stock is now approaching its 52-week high of $105.47. Investors should monitor the company’s upcoming events and progress in its AI drug discovery pipeline, which has been highlighted as a key growth area.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
Twist Bioscience Corporation (TWST) Q3 2026 Earnings Call August 3, 2026 8:00 AM EDTCompany ParticipantsAngela Bitting - Chief Corporate Responsibility...
7d agoYahoo TopBULLISH 68Earnings
Twist Bioscience Q3 Earnings Call Highlights
Twist Bioscience (NASDAQ:TWST) reported fiscal 2026 third-quarter revenue of $118.4 million, up 23% from a year earlier, marking its 14th consecutive quarter of growth. The company raised its full-year revenue outlook and said it remains on track to reach adjusted EBITDA breakeven in the fiscal four
7d agoInvestors.comBEARISH 38Earnings
Why This Top-Notch Trio Of Biotech Stocks Just Took A Tumble
Top-notch biotech stocks TG Therapeutics and Twist Bioscience took a tumble Monday on mixed second-quarter reports.
7d agoMarketChameleonBULLISH 63Earnings
Twist Bioscience Highlights R&D Momentum and Custom Solutions in Fiscal Q3 2026 Results
August 3, 2026
Twist Bioscience reports its fiscal third quarter 2026 results, underscoring innovation in biotech solutions and continued investment in research and development. The company also updates investors on upcoming events and advancements in customizable research products.
7d agoInvestorsHubBEARISH 38Earnings
Twist Bioscience Shares Decline Following Quarterly Earnings Miss
Twist Bioscience shares fell after the company missed fiscal third-quarter earnings estimates despite reporting stronger-than-expected revenue, as investors remained focused on profitability trends.
7d agoInvesting.com MarketsBEARISH 42General
Why is Twist Bioscience stock sliding today?
Why is Twist Bioscience stock sliding today?
7d agoBarron'sBULLISH 56General
S&P 500 Futures Up in Premarket Trading; GameStop, Twist Bioscience Lag
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →